Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (AI) Virus H5 Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored AI Vaccine

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cui, Hongyu ^a   Gao, Hongbo ^a   Cui, Xianlan ^b   Zhao, Yan ^a   Shi, Xingming ^a   Li, Qiaoling ^a   Yan, Shuai ^a   Gao, Ming ^a   Wang, Mei ^a   Liu, Changjun ^a   Wang, Yunfeng ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; HEMAGGLUTININ GENE; HERPES VIRUS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA VIRUS A H5N1; MARDIVIRUS; MAREK DISEASE VIRUS TYPE 1; NONHUMAN; PROTEIN EXPRESSION; TURKEY (BIRD); VACCINATION; VIREMIA; VIRUS GENE; VIRUS STRAIN; VIRUS VIRULENCE; WESTERN BLOTTING;

ANIMALS; BIRDS; CHICK EMBRYO; CHICKENS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HERPESVIRUS 1, MELEAGRID; HERPESVIRUS 2, GALLID; INFLUENZA A VIRUS, H5N1 SUBTYPE; MAREK DISEASE; MICROSCOPY, FLUORESCENCE; OPEN READING FRAMES; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; VIRAL VACCINES;

ANIMALIA; AVIAN INFLUENZA VIRUS; GALLID HERPESVIRUS 2; GALLUS GALLUS; HUMAN HERPESVIRUS 5; MELEAGRID HERPESVIRUS 1; RHODOCOCCUS RHODOCHROUS;

EID: 84871909849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053340     Document Type: Article

References (52)

1. Palese P, Shaw M (2007) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology, 5th edition. Philadelphia: Lippincott Williams & Wilkins. 1647-1689.
2. Pavlova SP, Veits J, Mettenleiter TC, Fuchs W, (2009) Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 27: 5085-5090.
3. Alexander DJ, (2007) An overview of the epidemiology of avian influenza. Vaccine 25(30): 5637-5644.
4. Van Kerkhove MD, Mumford E, Mounts AW, Bresee J, Ly S, et al. (2011) Highly Pathogenic Avian Influenza (H5N1): Pathways of Exposure at the Animal-Human Interface, a Systematic Review. PLoS ONE 6(1): e14582.
5. Capua I, Schmitz A, Jestin V, Koch G, Marangon S, (2009) Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006. Rev Sci Tech 28: 245-259.
6. Capua I, Marangon S, (2000a) The avian influenza epidemic in Italy, 1999-2000: a review. Avian Pathol 29: 289-294.
7. Capua I, Marangon F, Dalla Pozza M, Santucci U, (2000b) Vaccination for avian influenza in Italy. Vet Rec 147: 751.
8. Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al. (2006) Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 103: 8197-8202.
9. Schroer D, Veits J, Grund C, Dauber M, Keil G, et al. (2009) Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis 53: 190-197.
10. Oveissi S, Omar AR, Yusoff K, Jahanshiri F, Hassan SS, (2010) DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens. Comp Immunol Microbiol Infect Dis 33: 491-503.
11. Jiang Y, Yu K, Zhang H, Zhang P, Li C, et al. (2007) Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res 75: 234-241.
12. Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E, (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
13. Schat KA, Nair V (2008) Marek's disease. In: Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK, Swayne DE, editors. Diseases of Poultry, 12th edition. Ames, IA, USA: Blackwell Publishing. 452-514.
14. Spatz SJ, Zhao Y, Petherbridge L, Smith LP, Baigent SJ, et al. (2007) Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus. Virus Genes 35 (3): 753-766.
15. Shi WS, Liu CJ, Zhang YP, Qin YA, Zhang XW, et al. (2008) [Cloning and sequence analysis of the Meq gene of 4 Marek's disease virus isolates from China]. Bing Du Xue Bao 24: 117-125.
16. Liu AL, Liu CJ, Zhang YP, Li JM, Shi WS, et al. (2009) [Mutational analysis of Meq, RLORF4, RLORF12 and 132bpr genes of epidemic Marek's disease virus strains highly passaged on chicken embryo fibroblast]. Bing Du Xue Bao 25: 368-375.
17. Cui H, Wang Y, Shi X, Tong G, Lan D, et al. (2008) [Construction of Marek's disease virus serotype 814 strain as an infectious bacterial artificial chromosome]. Sheng Wu Gong Cheng Xue Bao 24: 569-575.
18. Li Y, Reddy K, Reid SM, Cox WJ, Brown IH, et al. (2011) Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease. Vaccine 29: 8257-8266.
19. Tsukamoto K, Kojima C, Komori Y, Tanimura N, Mase M, et al. (1999) Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257: 352-362.
20. Ge J, Deng G, Wen Z, Tian G, Wang Y, et al. (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81: 150-158.
21. Yun SL, Zhang W, Liu WJ, Zhang XR, Chen SJ, et al. (2009) [Construction of recombinant fowlpox virus coexpressing HA gene from H5N1 avian influenza virus and chicken interleukin-2 gene and assessment of its protective efficacy]. Bing Du Xue Bao 25: 430-436.
22. Morgan RW, Gelb J Jr, Schreurs CS, Lutticken D, Rosenberger JK, et al. (1992) Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis 36: 858-870.
23. Bublot M, Pritchard N, Le Gros FX, Goutebroze S, (2007) Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. J Comp Pathol 137Suppl 1: S81-84.
24. Tsukamoto K, Saito S, Saeki S, Sato T, Tanimura N, et al. (2002) Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J Virol 76: 5637-5645.
25. Darteil R, Bublot M, Laplace E, Bouquet JF, Audonnet JC, et al. (1995) Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211: 481-490.
26. Reddy SK, Sharma JM, Ahmad J, Reddy DN, McMillen JK, et al. (1996) Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14: 469-477.
27. Heckert RA, Riva J, Cook S, McMillen J, Schwartz RD, (1996) Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis 40: 770-777.
28. Sakaguchi M, Nakamura H, Sonoda K, Okamura H, Yokogawa K, et al. (1998) Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. Vaccine 16: 472-479.
29. Zhou X, Wang D, Xiong J, Zhang P, Li Y, et al. (2010) Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein. Vaccine 28: 3990-3996.
30. Gao H, Cui H, Cui X, Shi X, Zhao Y, et al. (2011) Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site. PLoS ONE 6: e22549.
31. Prandini F, Bublot M, Le Gros FX, Dancer A, Pizzoni L, et al. (2008) Assessment of the immune response in broilers and pullets using two ELISA kits after in ovo or day-old vaccination with a vectored vaccine (VAXXITEK® HVT+IBD). Zootecnica International Sep: 40-50.
32. Morgan RW, Gelb J Jr, Pope CR, Sondermeijer PJ, (1993) Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Dis 37: 1032-1040.
33. Ross LJ, Binns MM, Tyers P, Pastorek J, Zelnik V, et al. (1993) Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol 74(Pt 3): 371-377.
34. Zelnik V, Tyers P, Smith GD, Liang C, Ross NL, (1995) Structure and properties of a herpesvirus of turkeys recombinant in which US1, US10 and SORF3 genes have been replaced by a lacZ expression cassette. J Gen Virol 76(Pt 11): 2903-2907.
35. Baigent SJ, Petherbridge LJ, Smith LP, Zhao Y, Chesters PM, et al. (2006) Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 87: 769-776.
36. Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL, (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18: 1088-1095.
37. Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, et al. (2009) Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS ONE 4: e6509.
38. China developed recombinant avian influenza and Newcastle disease vaccine. Available: http://www.gov.cn/fwxx/kp/2005-12/26/content_136997.htm. Accessed 22 July, 2012.
39. Chen H, (2009) H5N1 avian influenza in China. Sci China C Life Sci 52(5): 419-427.
40. Lüschow D, Werner O, Mettenleiter TC, Fuchs W, (2001) Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19: 4249-4259.
41. Veits J, Lüschow D, Kindermann K, Werner O, Teifke JP, et al. (2003) Deletion of the nonessential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84: 3343-3352.
42. Liu J, Chen P, Jiang Y, Wu L, Zeng X, et al. (2011) A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. J Virol 85: 10989-10998.
43. Witter RL, (1987) New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: compar-ative efficacy. Avian Dis 31: 752-765.
44. Witter RL, (1991) Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy. Avian Dis 35: 877-891.
45. Tong K, Lin Y, Xiu Y, Fu T, Li C, (1984) Study on the immunization of chickens against Marek's disease: Report on a naturally avirulent vaccine strain of Marek's disease herpesvirus. Acta Veterinaria et Zootechnica Sinica 15: 109-113.
46. Xia CY, Guan YT, Nan X, Yu WT, Chen HY, (2000) Test of virulent Marek's disease virus Jing-1 strain infection in BWEL-SPF chicks. Chin J Vet Sci Technol 30: 24-25.
47. Liu CN, Liu M, Zhang Y, Liu CG, Gao XL, (2006) Pathogenicity of H5N1 Influenza Virus for Ducks. Scientia Agricultura Sinica 39: 412-417.
48. Cui S, Tong G, (2008) A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J Vet Diagn Invest 20: 567-571.
49. Cui HY, Wang YF, Shi XM, An TQ, Tong GZ, et al. (2009) Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens. J Virol Methods 156: 66-72.
50. Schumacher D, Tischer BK, Fuchs W, Osterrieder N, (2000) Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol 74: 11088-11098.
51. Tarnowski BI, Spinale FG, Nicholson JH, (1991) DAPI as a useful stain for nuclear quantitation. Biotech Histochem 66: 296-302.
52. Lee LF, Lupiani B, Silva RF, Kung HJ, Reddy SM, (2008) Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26: 1887-1892.